MEDICATION USE OF HEART FAILURE TREATMENT IN 2022: A STUDY AT A GRADE I HOSPITAL, HO CHI MINH CITY
Main Article Content
Abstract
Introduction: Heart failure is a chronic disease of growing concern due to its high morbidity and mortality rates, posing a significant economic burden on the healthcare system. There have been limited studies evaluating the use of heart failure medications to assess current practices and propose strategies to enhance treatment effectiveness. Objective: To analyze the medication usage patterns for heart failure treatment at Military Hospital 175. Methods: A retrospective study was conducted using electronic medical records of inpatients with a primary diagnosis of heart failure at Military Hospital 175 in 2022. The study focused on analyzing specific drug groups used during heart failure treatment. Results: A total of 312 inpatients with heart failure were included, with an average age of 67.1 ± 14.9 years. Diuretics were the most commonly prescribed medication (244 patients), followed by mineralocorticoid receptor antagonists (225 patients) and magnesium/potassium supplements (222 patients). Among 278 patients using other cardiovascular drugs, anticoagulants were the most frequently used (246 patients), followed by statins (217 patients). Conclusion: This study provides an in-depth analysis of heart failure medication use at Military Hospital 175, offering valuable insights for healthcare leaders into the burden of heart failure. These findings can support the development of effective strategies for resource allocation and management of heart failure treatment.
Article Details
Keywords
drug usage, heart failure, inpatient
References

2. Đỗ Thị Nam Phương and Nguyễn Anh Duy Tùng. Khảo sát các yếu tố tiên lượng tử vong trên bệnh nhân suy tim phân suất tống máu giảm nhập viện tại Viện Tim TPHCM. 2019 29/05/2022]; Available from: https://timmachhoc. vn/khao-sat-cac-yeu-to-tien-luong-tu-vong-tren-benh-nhan-suy-tim-phan-suat-tong-mau-giam-nhap-vien-tai-vien-tim-tp-hcm/.

3. E. B. Reyes, J.-W. Ha, I. Firdaus, A. M. Ghazi, A. Phrommintikul, D. Sim, Q. N. Vu, C. W. Siu, W.-H. Yin, and M. R. Cowie, Heart failure across Asia: same healthcare burden but differences in organization of care. International journal of cardiology, 2016. 223: p. 163-167.

4. T. Yingchoncharoen, T.-C. Wu, D.-J. Choi, T. K. Ong, H. B. Liew, and M.-C. Cho, Economic burden of heart failure in Asian countries with different healthcare systems. Korean circulation journal, 2021. 51(8): p. 681-693.

5. E. Kim, H.-Y. Kwon, S. H. Baek, H. Lee, B.-S. Yoo, S.-M. Kang, Y. Ahn, and B.-M. Yang, Medical costs in patients with heart failure after acute heart failure events: one-year follow-up study. Journal of Medical Economics, 2018. 21(3): p. 288-293.

6. Bộ Y tế. Các yếu tố nguy cơ dẫn đến bệnh tim mạch. 2015 29/04/2023]; Available from: https://moh.gov.vn/chuong-trinh-muc-tieu-quoc-gia/-/asset_publisher/7ng11fEWgASC/content/ cac-yeu-to-nguy-co-dan-en-benh-tim-mach?inheritRedirect=false#:~:text=Nh%C3%ACn%20chung%2C%20nam%20gi%E1%BB%9Bi%20c%C3%B3,ph%E1%BB%A5%20n%E1%BB%AF%20l%C3%A0%20nh%C6%B0%20nhau.

7. A. H. Behnoush, A. Khalaji, N. Naderi, H. Ashraf, and S. von Haehling, ACC/AHA/HFSA 2022 and ESC 2021 guidelines on heart failure comparison. ESC Heart Failure, 2023. 10(3): p. 1531-1544.

8. V. Sundaram, T. Nagai, C.-E. Chiang, Y. N. Reddy, T.-F. Chao, R. Zakeri, C. Bloom, M. Nakai, K. Nishimura, and C.-L. Hung, Hospitalization for heart failure in the United States, UK, Taiwan, and Japan: an international comparison of administrative health records on 413,385 individual patients. Journal of Cardiac Failure, 2022. 28(3): p. 353-366.
